Skip Navigation

Profile

Anthony Atala, M.D.Wake Forest Baptist Health

Doctor Rating

4.4 out of 5

49 Ratings
6 Comments
 

Anthony Atala, M.D.

Chair,
Director,
Professor,


Clinical Interests

Urology, Adolescent Urology, Microsurgery, Pediatric Urology, Reconstructive Urology

Contact Information

Returning Patient Appointments: 336-716-4131
Department: 336-716-4131

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.A., University of Miami, 1984
  • M.D., University of Louisville School of Medicine, 1985
  • Internship, U Louisville Affil Hosps, 1986
  • Residency, U Louisville Affil Hosps, 1990
  • Fellowship, Harvard Medical School, 1991
  • Fellowship, Harvard Medical School, 1992

Board Certifications

  • American Board of Urology, Pediatric Urology
  • American Board of Urology, Urology

Memberships

  • Soc Of Genitourinary Reconstru
  • Institute of Medicine
  • American Association of Genito
  • Am Coll Of Surgeons

NPI Number

  • 1235111832
Anthony Atala, M.D.

Doctor Rating

4.4 out of 5

49 Ratings
6 Comments
 

Anthony Atala, M.D.

Chair, Urology
Director, Institute for Regenerative Medicine
Professor, Urology
Institute for Regenerative Medicine
Office of Women in Medicine and Science

Research Interests

Tissue Engineering; Regenerative Medicine; Prostatic Neoplasms; Tissue Scaffolds; Stem Cells
More »

Contact Information

Academic: 336-716-5701 | Department: 336-716-4131

Media Medical Expert »

Recent Publications

Cell therapy for stress urinary incontinence: present-day frontiers. Vinarov A, Atala A, Yoo J, Slusarenco R, Zhumataev M, Zhito A, Butnaru D.. J Tissue Eng Regen Med. 2018;12(2):e1108-1121.

Immunomodulatory cell therapy to target cystic fibrosis inflammation. Khoury O, Barrios C, Ortega V, Atala A, Murphy SV.. Am J Respir Cell Mol Biol. 2018;58(1):12-20.

Controlled release of insulin-like growth factor 1 enhances urethral sphincter function and histological structure in the treatment of female stress urinary incontinence in a rat model. Yan H, Zhong L, Jiang Y, Yang J, Deng J, Wei S, Opara E, Atala A, Mao X, Damaser M, Zhang Y.. BJU Int. 2018;121(2):301-312.

Self-assembled liver organoids recapitulate hepato-biliary organogenesis in vitro. Vyas D, Baptista PM, Brovold M, Moran E, Brovold M, Gaston B, Booth C, Samuel M, Atala A, Soker S.. Hepatology. 2018;67(2):750-761.

Regenerative medicine: progressing toward cures [editorial]. Atala A.. Stem Cells Transl Med. 2018;7(1):1-2.

Preface [editorial]. Atala A.. Curr Stem Cell Res Ther. 2018;3(1):2.

3D bioprinted functional and contractile cardiac tissue constructs. Wang Z, Lee SJ, Cheng HJ, Yoo JJ, Atala A.. Acta Biomater. 2018;70():48-56.

The potential of 3D printing in urological research and patient care. Colaco M, Igel DA, Atala A.. Nat Rev Urol. 2018;15(4):213-221.

In situ tissue regeneration of renal tissue induced by collagen hydrogel injection. Lee SJ, Wang HJ, Kim TH, Choi JS, Kulkarni G, Jackson JD, Atala A, Yoo JJ.. Stem Cells Transl Med. 2018;7(2):241-250.

A human bone marrow mesodermal-derived cell population with hemogenic potential. Mokhtari S, Colletti E, Yin W, Sanada C, Lamar Z, Simmons PJ, Walker S, Bishop C, Atala A, Zanjani ED, Porada CD, Almeida-Porada G.. Leukemia. 2018;():.

Effect of environmental toxins on spermatogonial stem cells. McAbee KE, Pendergraft SS, Atala A, Bishop C, Sadri-Ardekani H. In: Sikka SC, Hellstrom WJG, eds. Bioenvironmental issues affecting men's reproductive and sexual health. New York (NY): Elsevier;2018: 53-70.

History and development of regenerative medicine and tissue engineering in urology. Rothberg MB, Atala A. In: Patel SR, Moran ME, Nakada SY, eds. The history of technologic advancements in urology. Cham (CH): Springer;2018: 289-317.

Bioreactors for regenerative medicine in urology. Ko IK, Atala A, Yoo JJ. In: Kim BW, ed. Clinical regenerative medicine in urology. Singapore (SG): Springer;2018: 87-104.

Biomaterials and tissue engineering. Lee SJ, Yoo JJ, Atala A. In: Kim BW, ed. Clinical regenerative medicine in urology. Singapore (SG): Springer;2018: 17-51.

Stem cell therapy for erectile dysfunction. Matz EL, Terlecki R, Zhang Y, Jackson J, Atala A.. Sex Med Rev. 2018;():.

Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells. Peak TC, Praharaj PP, Panigrahi GK, Doyle M, Su Y, Schlaepfer IR, Singh R, Vander Griend DJ, Alickson J, Hemal A, Atala A, Deep G.. Biochem Biophys Res Commun. 2018;499(4):1004-1010.

Environmental toxin screening using human-derived 3D bioengineered liver and cardiac organoids. Forsythe SD, Devarasetty M, Shupe T, Bishop C, Atala A, Soker S, Skardal A.. Front Public Health. 2018;6():103.

Human testicular organoid system as a novel tool to study Zika virus pathogenesis [letter]. Strange DP, Zarandi NP, Trivedi G, Atala A, Bishop CE, Sadri-Ardekani H, Verma S.. Emerg Microbes Infect. 2018;7(1):82.

Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling. Nzou G, Wicks RT, Wicks EE, Seale SA, Sane CH, Chen A, Murphy SV, Jackson JD, Atala AJ.. Sci Rep. 2018;8(1):7413.

Comparative analysis of two porcine kidney decellularization methods for maintenance of functional vascular architectures. Zambon JP, Ko IK, Abolbashari M, Huling J, Clouse C, Kim TH, Smith C, Atala A, Yoo JJ.. Acta Biomater. 2018;():.

Muscle tissue regeneration using muscle fiber fragments. Atala A, Yoo J Ko I, inventors; Wake Forest University Health Sciences, assignee.. Japan patent JP 6196217. 2017 Aug 25; United States patent US 9962466. 2018 May 8; European patent EP 2744503. 2018 July 20 (patent also held in Germany , France and United Kingdom. 2018;():.

Non-viral episomal suicide construct. Lu B, Zhao Q, Yoo J, Atala A, inventors; Wake Forest University Health Sciences, assignee.. United States patent US 9870278. 2018 Jan 30. 2018;():.

Tissue-specific extracellular matrix with or without tissue protein components for cell culture. Zhang Y, Soker S, Atala A, Skardal A, inventors; Wake Forest University Health Sciences, assignee.. United States patent US 9938502. 2018 Apr 10. 2018;():.

Skeletal myogenic differentiation of human urine-derived cells as a potential source for skeletal muscle regeneration. Chen W, Xie M, Yang B, Bharadwaj S, Song L, Liu G, Yi S, Ye G, Atala A, Zhang Y.. J Tissue Eng Regen Med. 2017;11(2):334-341.

Ibuprofen loaded PLA nanofibrous scaffolds increase proliferation of human skin cells in vitro and promote healing of full thickness incision wounds in vivo. Mohiti-Asli M, Saha S, Murphy SV, Gracz H, Pourdeyhimi B, Atala A, Loboa EG.. J Biomed Mater Res B Appl Biomater. 2017;105(2):327-339.

The potential role of tissue-engineered urethral substitution: clinical and preclinical studies. Atala A, Danilevskiy M, Lyundup A, Glybochko P, Butnaru D, Vinarov A, Yoo JJ.. J Tissue Eng Regen Med. 2017;11(1):3-19.

A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery. Skardal A, Murphy SV, Crowell K, Mack D, Atala A, Soker S.. J Biomed Mater Res B Appl Biomater. 2017;105(7):1986-2000.

Microencapsulation of porcine thyroid cell organoids within a polymer microcapsule construct. Yang Y, Opara EC, Liu Y, Atala A, Zhao W.. Exp Biol Med (Maywood). 2017;242(3):286-296.

Tissue engineering: toward a new era of medicine. Shafiee A, Atala A.. Annu Rev Med. 2017;68():29-40.

3D bioprinting of urethra with PCL/PLCL blend and dual autologous cells in fibrin hydrogel: an in vitro evaluation of biomimetic mechanical property and cell growth environment. Zhang K, Fu Q, Yoo J, Chen X, Chandra P, Mo X, Song L, Atala A, Zhao W.. Acta Biomater. 2017;50():154-164.

Urological tissue cultures [commentary]. Atala A.. J Urol. 2017;197(2 Suppl):S15-S16.

Editorial: future directions for stem cell banking and therapy. McAllister T, Atala A.. Curr Stem Cell Res Ther. 2017;12(1):2.

Acellular urethra bioscaffold: decellularization of whole urethras for tissue engineering applications. Simoes IN, Vale P, Soker S, Atala A, Keller D, Noiva R, Carvalho S, Peleteiro C, Cabral JM, Eberli D, da Silva CL, Baptista PM.. Sci Rep. 2017;7():41934.

Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Zhang YS, Aleman J, Shin SR, Kilic T, Kim D, Mousavi Shaegh SA, Massa S, Riahi R, Chae S, Hu N, Avci H, Zhang W, Silvestri A, Sanati Nezhad A, Manbohi A, De Ferrari F, Polini A, Calzone G, Shaikh N, Alerasool P, Budina E, Kang J, Bhise N, Ribas J,.. Proc Natl Acad Sci U S A. 2017;114(12):E2293-2302.

Advancing the translation of stem cells to medicine [editorial]. Atala A.. Stem Cells Transl Med. 2017;6(1):1-2.

No evidence of genome editing activity from Natronobacterium gregoryi Argonaute (NgAgo) in human cells. Javidi-Parsijani P, Niu G, Davis M, Lu P, Atala A, Lu B.. PLoS One. 2017;12(5):e0177444.

Tissue-specific extracellular matrix enhances skeletal muscle precursor cell expansion and differentiation for potential application in cell therapy. Zhang D, Zhang Y, Zhang Y, Yi H, Wang Z, Wu R, He D, Wei G, Wei S, Hu Y, Deng J, Criswell T, Yoo JJ, Zhou Y, Atala A.. Tissue Eng Part A. 2017;23(15-16):784-794.

Transforming the approach to cell-based therapies [editorial]. Atala A, McAllister TN.. Stem Cells Transl Med. 2017;6(5):1305-1306.

In vitro skin expansion: wound healing assessment. Prim PM, Kim HS, Shapiro LE, Lee JS, Kaan JH, Jackson JD, Yoo JJ, Atala A, Lee SJ.. Wound Repair Regen. 2017;25(3):398-407.

Selective cell therapy for the treatment of renal failure. Atala A, Yoo JJ, inventors; Wake Forest University Health Sciences, assignee.. United States patent US 9534203. 2017 Jan 3. 2017;():.

Kidney structures and methods of forming the same. Atala A, Yoo JJ, inventors; Wake Forest University Health Sciences, assignee.. United States patent US 9580688. 2017 Feb 28. 2017;():.

Tissue expander. Atala A, Lee SJ, Yoo JJ, Scarpinato P, Ladd MR, inventors; Wake Forest University Health Sciences, assignee.. United States patent US 9585688. 2017 Mar 7. 2017;():.

Inkjet gene printing. Atala A, Yoo JJ, Xu T, inventors; Wake Forest University Health Sciences, assignee.. United States patent US 9598704. 2017 Mar 21. 2017;():.

Regenerative medicine: current concepts and changing trends [abstract]. Atala A.. In Vitro Cell Dev Biol Anim. 2017;53(Suppl 1):S1.

Optical tracking and digital quantification of beating behavior in bioengineered human cardiac organoids. Devarasetty M, Forsythe S, Shupe TD, Soker S, Bishop CE, Atala A, Skardal A.. Biosensors (Basel). 2017;7(3):E24.

Electrospun vascular scaffold for cellularized small diameter blood vessels: a preclinical large animal study. Ju YM, Ahn H, Arenas-Herrera J, Kim C, Abolbashari M, Atala A, Yoo JJ, Lee SJ.. Acta Biomater. 2017;59():58-67.

Novel applications of calcium channel blockers: a new insight to cardiac drugs [abstract]. Motayagheni N, Hyre A, Mirzazadeh M, Subashchandrabose S, Atala A.. Cardiology. 2017;137(Suppl 1):43.

A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. Davies BM, Smith J, Rikabi S, Wartolowska K, Morrey M, French A, MacLaren R, Williams D, Bure K, Pinedo-Villanueva R, Mathur A, Birchall M, Snyder E, Atala A, Reeve B, Brindley D.. J Tissue Eng. 2017;8():.

The potential role of stem cells in the treatment of fecal incontinence following posterior sagittal anorectoplasty operation [abstract]. Gadallah N, El-Okby A, El-Badawy R, Bakry S, El Bahrawy M, Atala A.. Neurourol Urodyn. 2017;36(Suppl 3):S239-S241.

Tissue-specific extracellular matrix promotes myogenic differentiation of human muscle progenitor cells on gelatin and heparin conjugated alginate hydrogels. Yi H, Forsythe S, He Y, Liu Q, Xiong G, Wei S, Li G, Atala A, Skardal A, Zhang Y.. Acta Biomater. 2017;62():222-233.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Urology
Institute for Regenerative Medicine

Clinical Interests

Urology, Adolescent Urology, Microsurgery, Pediatric Urology, Reconstructive Urology
Anthony Atala, M.D.

Anthony Atala, M.D.

Chair, Urology
Director, Institute for Regenerative Medicine
Professor, Urology
Institute for Regenerative Medicine
Office of Women in Medicine and Science

Doctor Rating

4.4 out of 5

Anthony Atala, M.D.49 Ratings
6 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.4
CP efforts to include in decisions
4.4
CP explanations of prob/condition
4.5
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.5
Patients' confidence in CP
4.6
Time CP spent with patient
4.4
Wait time at clinic
3.8



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/30/2018

He is the kindest doctor I have ever had the honor of meet with when I have interacted.

5/11/2018

good

4/16/2018

Dr. Atala was AWESOME! He treated us with such great care & respect. He was able to figure out my health problem that another Urologist wasn't able to decipher. He explained everything clearly & made sure we knew what to do before we left. I have recommended him to everyone we've seen.

1/31/2018

*Dr. Atala is such a blessing to his patients. I feel very fortunate that my infant was in such great hands. he was very reassuring that my little baby's surgery would go great, and it did.

1/20/2018

Dr. Atala was excellent with Izzy. He spoke with her and interacted in a way that made her (a child) feel comfortable in what could have been a very uncomfortable situation.

11/20/2017

he scheduled a test for my daughter in 3 months but didn't give us much information on what the test would entail. he also told us he would do surgery in April as long as the test in January looked good but he gave us no information on what we could expect with the surgery.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.